Limassol Medical Centre Introduces First Robotic Exoskeleton in Cyprus
In a landmark development for Cyprus’ rehabilitation services, the Limassol-based Melanthron Agoniston Eoka medical centre has proudly acquired the nation’s first robotic exoskeleton, a move that promises to revolutionize the treatment and support for individuals with walking impairments.
The medical centre has invested over €200,000 in the EksoNR, a state-of-the-art robotic exoskeleton specifically designed to aid those struggling with mobility due to neurological conditions or injuries. The health ministry has significantly contributed to this acquisition, providing €100,000 through a medical equipment subsidy scheme.
At the unveiling ceremony on Thursday morning, Antonis Charalambous, President of the Board of Directors at Melanthron Agoniston Eoka, committed to the centre’s ongoing evolution and dedication to offering top-tier services that will significantly bolster the rehabilitation sector in Cyprus.
Professor of Neurology and the centre’s scientific director, Georgios Kaponides, highlighted that robotic exoskeletons are at the cutting edge of technology, aimed at restoring walking abilities in patients affected by strokes, traumatic brain injuries, multiple sclerosis, and spinal cord injuries.
The EksoNR is designed to support patients in bearing their own weight while providing postural alignment assistance. It is also FDA-cleared for use with various conditions, including ABI and MS. However, Kaponides noted that not all patients are eligible for this treatment as they must meet specific criteria regarding height and weight.
This groundbreaking technology is being deployed for the first time in Cyprus, with around 256 similar units across Europe and four in Greece. Dr Stavros Stavrou, Chief Medical Officer and Inspector of Private Hospitals, expressed the health ministry’s satisfaction with the collaboration on this project.
The addition of this robotic system is expected to greatly facilitate the rehabilitation process for patients with severe musculoskeletal and neurological issues, enhancing their walking and balance capabilities. The press conference also featured a live demonstration by a patient with multiple sclerosis, showcasing the exoskeleton’s capabilities under the guidance of Dr Konstantinos Tzitzikosta, a physiatrist and rehabilitation physician.
This investment marks a significant milestone for Cyprus’ healthcare sector, offering new hope and improved treatment options for patients requiring rehabilitation services.
